2031년까지의 남미 및 중미 생물공정 시장 전망 - 지역 분석 - 제품별(기기 및 소모품 및 액세서리), 운영 규모(상업 운영 및 임상 운영), 공정(하류 생물공정 및 상류 생물공정), 응용 분야(단일클론 항체, 백신, 재조합 단백질, 세포 및 유전자 치료 및 기타), 최종 사용자(생물제약 회사, 계약 제조 기관 및 기타)
개인 맞춤 의료에 대한 급증하는 수요가 남미 및 중미 생물가공 시장을 촉진합니다
의료 산업이 일률적 접근 방식에서 타깃팅된 접근 방식으로 전환되면서 개인 맞춤 의료에 대한 수요가 확대되고 있습니다. 정밀 의학은 암, 신경 퇴행성 질환, 희귀 유전적 질환과 같은 건강 문제를 해결하는 가장 유망한 접근 방식 중 하나로 여겨지고 있습니다. 개인 맞춤 의약품 생산의 혁신은 전체 부문에 영향을 미칠 가능성이 높으며, 소량 생산을 목표로 하는 일회용 기술은 특히 하류 공정에서 단백질 생물 생산에 잠재적으로 적용될 수 있습니다. 개인화되고 차별화된 의학 접근 방식은 더 광범위한 제품에 대한 필요성으로 이어지고 있으며, 그 중 많은 제품이 비교적 소수의 환자를 대상으로 합니다. 따라서 생물학적 제품의 생산 및 제공에 대한 근본적으로 다른 접근 방식이 필요할 수 있습니다. 정밀 의학은 개인의 유전체 정보를 활용하여 특정 증상에 대한 표적 치료를 제공합니다. 희귀 질환의 증가로 인해 생물학제와 약물에 대한 수요가 증가했으며, 이로 인해 개인화된 의약품의 성장이 촉진되었습니다. 2019년 FDA는 질병의 근본 원인을 해결하고 정밀 의학을 임상 치료와 더욱 통합하기 위해 약 12개의 개인화된 약물을 승인했습니다. 또한 정부의 노력이 증가함에 따라 개인화된 의약품 연구 활동이 강화되고 있습니다. 예를 들어, 2020년 2월, 국립 인간 유전체 연구소(NHGRI)는 새로운 정밀 의학 및 유전체학 프로그램을 수립한다고 발표했습니다. 이 프로그램은 질병의 더 나은 진단 및 치료를 위한 유전체학 및 정보학 도구의 혁신에 중점을 둡니다. 개인화된 의약품은 유전학 및 생물정보학의 발전을 활용하여 특정 환자 집단을 표적으로 삼고 이전에는 치료할 수 없었던 질병을 치료합니다. 개인맞춤형 의학은 생물가공 기술을 사용하여 맞춤형 치료법을 개발합니다. 특정 세포를 분리하는 것부터 환자 맞춤형 치료법을 개발하는 것까지, 생물가공 단계는 각 환자에게 맞춤형 치료법을 생산하는 데 필수적입니다. 따라서 개인맞춤형 의학에 대한 수요 증가는 예측 기간 동안 생물가공 시장에서 활동하는 업체에 상당한 성장 기회를 제공할 것으로 예측됩니다.
남미 및 중미 생물가공 시장 개요
남미 및 중미 생물가공 시장은 브라질, 아르헨티나, 그리고 남미 및 중미의 나머지 지역으로 나뉩니다. 브라질은 예측 기간 동안 이 지역 시장에서 주요 점유율을 차지할 것으로 추정됩니다. 시장 참여자는 혁신적인 제품을 제공하여 경쟁에서 앞서 나가기 위해 R&D에 많은 투자를 합니다. 또한 현지 규정을 개선하면 다국적 생명공학 회사가 남미 및 중미 국가에 진출하여 제품을 제조하고 상용화할 수 있습니다. 지리적 확장을 위해 여러 글로벌 생명공학 회사는 과거에 경제 성장으로 인해 브라질 시장을 선택했습니다. 따라서 다양한 연구 활동의 급증, 의료비 지출 증가, 암과 자가면역 질환에 대한 치료 잠재력 향상, 생명공학에 대한 투자 증가, 강력한 약물 포트폴리오 개발을 위한 연구 협업 증가는 향후 몇 년 동안 남미 및 중미의 생물처리 시장에 기회를 창출할 것입니다.
남미 및 중미 생물처리 시장 수익 및 2031년 예측(백만 달러)
남미 및 중미 생물처리 시장 세분화
남미 및 중미 생물처리 시장은 제품, 운영 규모, 공정, 응용 프로그램, 최종 사용자 및 국가로 분류됩니다.
제품을 기준으로 남미 및 중미 생물처리 시장은 기기와 소모품 및 액세서리로 나뉩니다. 기기 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다. 또한 기기 세그먼트는 여과 장치, 생물 반응기, 크로마토그래피 시스템, 원심 분리기, 건조 장치 등으로 세분화됩니다. 또한, 생물 반응기 하위 세그먼트는 파일럿 규모, 풀 스케일 및 실험실 규모로 분류됩니다. 나아가, 하위 세그먼트 크로마토그래피 시스템은 액체 크로마토그래피, 가스 크로마토그래피 및 기타로 세분화됩니다. 또한, 소모품 및 액세서리 세그먼트는 시약, 세포 배양 배지, 크로마토그래피 수지 및 기타로 세분화됩니다.
운영 규모 측면에서, 남미 및 중미 생물 처리 시장은 상업적 운영과 임상 운영으로 나뉩니다. 상업적 운영 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다.
프로세스별로, 남미 및 중미 생물 처리 시장은 하류 생물 공정 및 상류 생물 공정으로 나뉩니다. 하류 생물 공정 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다.
응용 프로그램을 기준으로, 남미 및 중미 생물 처리 시장은 단일 클론 항체, 백신, 재조합 단백질, 세포 및 유전자 치료 및 기타로 분류됩니다. 단일클론 항체 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.
최종 사용자 측면에서 남미 및 중미 생물 처리 시장은 생물 제약 회사, 계약 제조 기관 및 기타로 분류됩니다. 생물 제약 회사 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.
국가별로 남미 및 중미 생물 처리 시장은 브라질, 아르헨티나 및 기타 남미 및 중미로 세분화됩니다. 브라질은 2023년에 남미 및 중미 생물 처리 시장 점유율을 지배했습니다.
Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Agilent Technologies Inc 및 Cytiva US LLC는 남미 및 중미 생물 처리 시장에서 운영되는 일부 선도 기업입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Bioprocessing Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Biopharmaceutical Industry
4.2 Market Restraints
4.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
4.3 Market Opportunities
4.3.1 Proliferating Demand for Personalized Medicine
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact of Drivers and Restraints:
5. Bioprocessing Market - South & Central America Analysis
5.1 South & Central America Bioprocessing Market Overview
5.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
6. South & Central America Bioprocessing Market Analysis - by Product
6.1 Overview
6.2 Instruments
6.2.1 Overview
6.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
6.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
6.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
6.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
6.3 Consumables & Accessories
6.3.1 Overview
6.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
7. South & Central America Bioprocessing Market Analysis - by Scale of Operation
7.1 Overview
7.2 Commercial Operations
7.2.1 Overview
7.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Clinical Operations
7.3.1 Overview
7.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8. South & Central America Bioprocessing Market Analysis - by Process
8.1 Overview
8.2 Downstream Bioprocess
8.2.1 Overview
8.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Upstream Bioprocess
8.3.1 Overview
8.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. South & Central America Bioprocessing Market Analysis - by Application
9.1 Overview
9.2 Monoclonal Antibodies
9.2.1 Overview
9.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Recombinant Protein
9.4.1 Overview
9.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Cell & Gene Therapy
9.5.1 Overview
9.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. South & Central America Bioprocessing Market Analysis - by End User
10.1 Overview
10.2 Biopharmaceutical Companies
10.2.1 Overview
10.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Contract Manufacturing Organization
10.3.1 Overview
10.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. South & Central America Bioprocessing Market - Country Analysis
11.1 South & Central America
11.1.1 South & Central America: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
11.1.1.1 Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.1.1 Overview
11.1.1.2 Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.2.1 Brazil: Bioprocessing Market Breakdown, by Product
11.1.1.2.1.1 Brazil: Bioprocessing Market Breakdown, by Instruments
11.1.1.2.1.1.1 Brazil: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.2.1.1.2 Brazil: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.2.1.2 Brazil: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.2.2 Brazil: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.2.3 Brazil: Bioprocessing Market Breakdown, by Process
11.1.1.2.4 Brazil: Bioprocessing Market Breakdown, by Application
11.1.1.2.5 Brazil: Bioprocessing Market Breakdown, by End User
11.1.1.3 Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.3.1 Overview
11.1.1.4 Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.4.1 Argentina: Bioprocessing Market Breakdown, by Product
11.1.1.4.1.1 Argentina: Bioprocessing Market Breakdown, by Instruments
11.1.1.4.1.1.1 Argentina: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.4.1.1.2 Argentina: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.4.1.2 Argentina: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.4.2 Argentina: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.4.3 Argentina: Bioprocessing Market Breakdown, by Process
11.1.1.4.4 Argentina: Bioprocessing Market Breakdown, by Application
11.1.1.4.5 Argentina: Bioprocessing Market Breakdown, by End User
11.1.1.5 Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.6.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Product
11.1.1.6.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Instruments
11.1.1.6.1.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.6.1.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.6.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.6.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.6.3 Rest of South & Central America: Bioprocessing Market Breakdown, by Process
11.1.1.6.4 Rest of South & Central America: Bioprocessing Market Breakdown, by Application
11.1.1.6.5 Rest of South & Central America: Bioprocessing Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Bioprocessing Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Getinge AB
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Corning Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 3M Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eppendorf SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Cytiva US LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
?
List of Tables
Table 1. South & Central America Bioprocessing Market Segmentation
Table 2. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 6. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 7. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 8. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 9. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 10. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 11. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 12. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 13. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 14. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 15. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 16. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 17. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 18. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 19. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 20. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 21. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 22. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 23. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 24. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 25. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 26. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 27. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 28. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 29. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 30. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 31. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 32. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 33. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 34. Recent Organic Growth Strategies in the Bioprocessing Market
Table 35. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. South & Central America Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. South & Central America: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. South & Central America: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Growth Strategies in the Bioprocessing Market
?
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.